Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;41(4):833-852.
doi: 10.1007/s10555-022-10045-3. Epub 2022 Jun 14.

Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective

Kristian M Hargadon  1 , Travis B Goodloe 3rd  2 , Nathaniel D Lloyd  2
Affiliations
Review

Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective

Kristian M Hargadon et al. Cancer Metastasis Rev. 2022 Dec.

Abstract

Epigenetic regulation of gene expression is a fundamental determinant of molecular and cellular function, and epigenetic reprogramming in the context of cancer has emerged as one of the key enabling characteristics associated with acquisition of the core hallmarks of this disease. As such, there has been renewed interest in studying the role of transcription factors as epigenetic regulators of gene expression in cancer. In this review, we discuss the current state of knowledge surrounding the oncogenic functions of FOXC2, a transcription factor that frequently becomes dysregulated in a variety of cancer types. In addition to highlighting the clinical impact of aberrant FOXC2 activity in cancer, we discuss mechanisms by which this transcription factor becomes dysregulated in both tumor and tumor-associated cells, placing particular emphasis on the ways in which FOXC2 promotes key hallmarks of cancer progression. Finally, we bring attention to important issues related to the oncogenic dysregulation of FOXC2 that must be addressed going forward in order to improve our understanding of FOXC2-mediated cancer progression and to guide prognostic and therapeutic applications of this knowledge in clinical settings.

Keywords: Angiogenesis; Drug resistance; Epithelial-mesenchymal transition; FOXC2; Hallmarks of cancer; Tumor metabolism.

PubMed Disclaimer

References

    1. Miura, N., Wanaka, A., Tohyama, M., & Tanaka, K. (1993). MFH-1, a new member of the fork head domain family, is expressed in developing mesenchyme. FEBS Letters, 326(1–3), 171–176. https://doi.org/10.1016/0014-5793(93)81785-X - DOI
    1. Xue, Y., Cao, R., Nilsson, D., Chen, S., Westergren, R., Hedlund, E. M., et al. (2008). FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proceedings of the National Academy of Sciences of the United States of America, 105(29), 10167–10172. https://doi.org/10.1073/pnas.0802486105 - DOI
    1. Hader, C., Marlier, A., & Cantley, L. (2010). Mesenchymal-epithelial transition in epithelial response to injury: The role of Foxc2. Oncogene, 29(7), 1031–1040. https://doi.org/10.1038/onc.2009.397 - DOI
    1. Motojima, M., Kume, T., & Matsusaka, T. (2017). Foxc1 and Foxc2 are necessary to maintain glomerular podocytes. Experimental Cell Research, 352(2), 265–272. https://doi.org/10.1016/J.YEXCR.2017.02.016 - DOI
    1. Cederberg, A., Gronning, L. M., Ahrén, B., Taskén, K., Carlsson, P., & Enerbäck, S. (2001). FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell, 106(5), 563–573. https://doi.org/10.1016/S0092-8674(01)00474-3 - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources